MAURIZI, NICCOLO'
 Distribuzione geografica
Continente #
NA - Nord America 1.095
EU - Europa 793
AS - Asia 192
AF - Africa 2
Totale 2.082
Nazione #
US - Stati Uniti d'America 1.092
PL - Polonia 294
IT - Italia 177
IE - Irlanda 136
SE - Svezia 121
HK - Hong Kong 69
CN - Cina 49
JO - Giordania 30
SG - Singapore 21
CH - Svizzera 14
RU - Federazione Russa 14
VN - Vietnam 13
ES - Italia 10
GB - Regno Unito 9
UA - Ucraina 6
KR - Corea 5
FR - Francia 4
RO - Romania 4
CA - Canada 3
DE - Germania 2
BE - Belgio 1
GE - Georgia 1
IN - India 1
IR - Iran 1
MU - Mauritius 1
PT - Portogallo 1
SC - Seychelles 1
TJ - Tagikistan 1
UZ - Uzbekistan 1
Totale 2.082
Città #
Warsaw 290
Fairfield 174
Dublin 136
Chandler 118
Ashburn 91
Woodbridge 83
Seattle 77
Wilmington 68
Cambridge 62
Lawrence 54
Houston 53
Altamura 52
Hong Kong 45
Ann Arbor 38
Florence 31
Princeton 30
Boston 27
Beijing 22
Shanghai 17
Scandicci 16
Bern 14
Buffalo 14
San Diego 14
Dong Ket 12
Singapore 12
Medford 10
Moscow 10
New York 10
Barcelona 9
Siena 7
Andover 6
Boardman 6
Falls Church 6
Fontebuona 6
Rome 5
Campi Bisenzio 4
Dearborn 4
Kent 4
Norwalk 4
Redmond 4
Salerno 4
Seoul 4
Castelfiorentino 3
Imola 3
Livorno 3
Timisoara 3
Bologna 2
Bondeno 2
Cesano Boscone 2
Easley 2
Hillsboro 2
London 2
Prato 2
St. Catharines 2
Thiene 2
Trinitapoli 2
Washington 2
West Jordan 2
Barletta 1
Berlin 1
Bruino 1
Brussels 1
Chicago 1
Council Bluffs 1
Duncan 1
Fuzhou 1
Genova 1
Gloucester 1
Hanoi 1
Harbin 1
Hounslow 1
Islington 1
Jinan 1
Kilburn 1
Lecce 1
Los Angeles 1
Mem Martins 1
Milan 1
Monte San Savino 1
Nanjing 1
Naples 1
Sesto Fiorentino 1
Shaoxing 1
Southwark 1
St Petersburg 1
Toronto 1
Turin 1
Totale 1.718
Nome #
"Tuscany Registry for sAdden Cardiac DEath": metodo per la creazione di un registro multicentrico per la gestione di eventi di morte improvvisa in età giovanile 291
Participation in thrill-seeking activities by patients with hypertrophic cardiomyopathy: Individual preferences, adverse events and physician attitude 129
Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy 109
Long-term Outcomes of Pediatric-Onset Hypertrophic Cardiomyopathy and Age-Specific Risk Factors for Lethal Arrhythmic Events 108
Clinical Course and Significance of Hypertrophic Cardiomyopathy Without Left Ventricular Hypertrophy 107
Intraoperative diagnosis of Anderson-Fabry disease in patients with obstructive hypertrophic cardiomyopathy undergoing surgical myectomy 107
Reversible dilated cardiomyopathy: into the thaumaturgy of the heart - Part 2 88
Association of Obesity with Adverse Long-term Outcomes in Hypertrophic Cardiomyopathy 75
The electrocardiogram in the diagnosis and management of patients with hypertrophic cardiomyopathy 74
Cardiovascular screening in low-income settings using a novel 4-lead smartphone-based electrocardiograph (D-Heart®) 71
Timing of invasive septal reduction therapies and outcome of patients with obstructive hypertrophic cardiomyopathy 69
Clinical and Molecular Aspects of Cardiomyopathies: Emerging Therapies and Clinical Trials 66
Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy 66
Common presentation of rare cardiac diseases: Arrhythmias 64
Effectiveness of subcutaneous implantable cardioverter-defibrillator testing in patients with hypertrophic cardiomyopathy 62
Cardiomyopathies in children – inherited heart muscle disease: Overview of hypertrophic, dilated, restrictive and non-compaction phenotypes 56
Prevalence of subcutaneous implantable cardioverter-defibrillator candidacy based on template ECG screening in patients with hypertrophic cardiomyopathy 55
Exercise testing in hypertrophic cardiomyopathy: A pathophysiological goldmine with protean clinical implications 54
Strength of clinical indication and therapeutic impact of the implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy 54
Age-dependent diagnostic yield of echocardiography as a second-line diagnostic investigation in athletes with abnormalities at preparticipation screening 53
Efficacy and safety of dysopiramide in patients with obstructive hypertrophic cardiomyopathy 45
Feasibility of a combined mobile-health electrocardiographic and rapid diagnostic test screening for chagas-related cardiac alterations 44
Genetic basis of pediatric sarcomeric hypertrophic cardiomyopathy: impact on long term outcome 41
Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac Amyloidosis 40
β-blockers: Their new life from hypertension to cancer and migraine 39
Predictive value of classic sudden death risk factors in pediatric-onset hypertrophic cardiomyopathy 38
Comparative analysis of a 4-lead portable smartphone-based versus standard 12-lead electrocardiograph for cardiovascular screening in low-income settings 36
Extra long term follow up of the original tuscany cohort of patients with hypertrophic cardiomyopathy 33
Sudden cardiac death in cardiomyopathies: acting upon “acceptable” risk in the personalized medicine era 27
Telemedicine cardiovascular screening program in low-income settings by smartphone based technology 15
null 7
Totale 2.123
Categoria #
all - tutte 7.205
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.205


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020493 5 4 4 11 21 37 103 101 82 48 61 16
2020/2021395 34 58 47 46 14 22 17 37 27 61 10 22
2021/2022211 5 8 17 7 4 11 10 18 19 15 34 63
2022/2023651 52 175 35 25 30 93 69 41 73 9 30 19
2023/2024264 6 23 30 11 13 60 16 61 5 13 15 11
2024/202519 19 0 0 0 0 0 0 0 0 0 0 0
Totale 2.123